Actualités Oncolytics Biotech Inc - ONC | Actions Toronto Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer PR Newswire CALGARY...

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer PR...

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders PR Newswire CALGARY, May 6, 2016 CALGARY, May 6...

Oncolytics Biotech® Inc. Announces 2016 First Quarter Results

Oncolytics Biotech® Inc. Announces 2016 First Quarter Results PR Newswire CALGARY, May 6, 2016 CALGARY, May 6, 2016 /PRNewswire/...

Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting

Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting PR Newswire CALGARY...

Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders

Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders PR Newswire CALGARY, May 3, 2016 CALGARY, May 3, 2016...

VIDEO: Oncolytics Biotech CEO Brad Thompson Interviewed in OTCQX Video Series

VIDEO: Oncolytics Biotech CEO Brad Thompson Interviewed in OTCQX Video Series PR Newswire NEW YORK, May 2, 2016 NEW YORK, May 2, 2016...

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference PR Newswire CALGARY, April 29, 2016...

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee PR Newswire CALGARY, April 29, 2016 CALGARY, April 29, 2016...

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting PR Newswire CALGARY...

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer PR Newswire CALGARY...

Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting

Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting PR Newswire CALGARY...

Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer

Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer PR Newswire CALGARY, March 21, 2016...

Oncolytics Biotech(R) Inc. Announces 2015 Year End Results

Oncolytics Biotech(R) Inc. Announces 2015 Year End Results PR Newswire CALGARY, March 11, 2016 CALGARY, March 11, 2016 /PRNewswire/ - Oncolytics...

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences PR Newswire CALGARY, Feb. 8, 2016 CALGARY, Feb. 8...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncolytics Biotech Inc (ONC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ONC Actualités

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

Oncolytics Biotech® Inc. Announces 2016 First Quarter Results

Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting

Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders

VIDEO: Oncolytics Biotech CEO Brad Thompson Interviewed in OTCQX Video Series

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer

Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting

Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer

Oncolytics Biotech(R) Inc. Announces 2015 Year End Results

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncolytics Biotech Inc (ONC) Actualités

Oncolytics Biotech Inc (ONC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ONC Actualités

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

Oncolytics Biotech® Inc. Announces 2016 First Quarter Results

Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting

Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders

VIDEO: Oncolytics Biotech CEO Brad Thompson Interviewed in OTCQX Video Series

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer

Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting

Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer

Oncolytics Biotech(R) Inc. Announces 2015 Year End Results

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités